 |
APPA's Fall Educational Conference to be held virtually
| |
Because of the continued spread of COVID-19, APPA's Executive Council has decided to conduct the fall conference virtually on Saturday, Oct. 10. Given the current situation and keeping the health and safety of our attendees in mind, they believe conducting the conference virtually is the responsible action.
We will hear from an outstanding lineup of speakers who will provide six hours of instruction, with breaks throughout the day to help eliminate screen fatigue.
Listed below are attendees whose registration was automatically transferred from the Spring Conference to the Fall. If you are on the list and are unable to participate in the Oct. 10 conference, please let us know. Please check the list before registering for the Fall Conference.
A grant from the American Psychiatric Association is providing free meeting registration for Early Career Psychiatrists*, Resident Fellow Members and students!
*Early Career Psychiatrists are General Members of the APA who are within their first seven years after completion of training.
| |
| Conference Spotlight: The Structure of Psychopathology:
An Evolutionary Approach
Marco Del Giudice, PhD
| |
Marco Del Giudice, PhD, is associate professor of psychology at the University of New Mexico. He earned his PhD in cognitive science from the University of Turin, Torino, Italy.
His work explores a broad range of topics at the intersection of human behavior, evolution, and development. He has published more than 90 papers and chapters, and won the 2016 Early Career Award of the Human Behavior and Evolution Society.
Dr. Del Giudice will present The Structure of Psychopathology: An Evolutionary Approach on Saturday, Oct. 10, at 8:15 a.m.
| |
| Conference Spotlight: The Pains of Dying: Psychodynamic and other Considerations Regarding Issues at the End of Life
Philip Muskin, MD, MA, DLFAPA
| |
Philip Muskin, MD, MA, DLFAPA, is professor of psychiatry at Columbia University Medical Center as well as a clinical supervisor, C-L clinician and private practitioner of psychiatry and psychoanalysis.
He is a graduate of Cornell University, the Graduate Faculty of the New School for Social Research, New York Medical College (AOA), and the Columbia University Psychoanalytic Center.
He he has published numerous articles, books, and chapters on topics including maladaptive denial of physical illness, the role of religiosity in DNR decisions, the psychodynamics of physician-assisted suicide, and decision-making capacity of medically ill patients.
Dr. Muskin will speak on The Pains of Dying: Psychodynamic and other Considerations Regarding Issues at the End of Life on Saturday, Oct. 10, at 9:00 a.m.
| |
|
Look Who's Coming
Glenn Archibald, MD, Psychiatric Health Services, LLC, Birmingham
Martha Tucker Ban, MD, Tuscaloosa VA Medical Center
Michael Banov, MD, PsychAtlanta, Marietta, GA
Pam Barnett, MD, Private Practice, Mobile
Nancy Bishop, BS, Alabama Department of Public Health, Montgomery
Emily Brewer, Mobile
William Burns, AltaPointe Health Systems, Mobile
Gabrielle A. Carlson, MD, Renaissance School of Medicine at Stony Brook University, NY
Jaria Chowdhury, MD, Alabama Psychiatry, Pelham
Mary Cohen-Colson, MD, AltaPointe Health Systems, Mobile
Marco Del Giudice, PhD, University of New Mexico Department of Psychiatry, Albuquerque, NM
J. Luke Engeriser, MD, AltaPointe Health Systems, Mobile
David R. Faber, MD, North Shelby Psychiatric Services, Helena
Andrew Friede, MD, MPH, FACPM, Pathway Healthcare, LLC, Birmingham
Meghana Gaini, University of Alabama School of Medicine, Madison
Maria Hamilton, MD, AltaPointe Health Systems, Mobile
Deborah Hogan, MD, Retired
Shyla Hossain, University of South Alabama, Mobile
Amy Hudson, UAB - Huntsville
Tina Jackson, MD, University of South Alabama, Mobile
James Jeffery, MD, Mental Health Center of North Central Alabama, Inc., Decatur
F. Cleveland Kinney, MD, PhD, University of Alabama - Birmingham
Jennifer Lamar, University of Alabama School of Medicine, Huntsville
Samantha Lee, University of South Alabama College of Medicine, Mobile
Fernando Lopez, MD, DLFAPA, SpectraCare, Dothan
Clinton Martin, MD, FAPA, UAB Huntsville Regional Medical Center
Daniel Mejer, MD, Private Practice, Pike Road
Philip R. Muskin, MD, MA, DLFAPA, Columbia University Medical Center, New York, NY
Praveen Narahari, MD, MS, AltaPoine Health Systems, Daphne
Charles Nevels, MD, Private Practice, Tuscaloosa
Janaki Nimmagadda, MD, UAB-Huntsville
Paul O'Leary, MD, FAPA, SHKO Medicine, LLC, Birmingham
Godehard Oepen, MD, PhD, DLFAPA, Grayson & Associates, Hoover
Abhilasha Pandey, MD, Charles Nevels, MD, Tuscaloosa
Sarah Peake, PharmD, Syneos Health - Jannsen Neuroscience, Atlanta, GA
Nicholas Rivers, UAB School of Medicine - Huntsville
Lindsey Stewart, MD, USA Health System, Mobile
Anna Tucker, RN, Grandview in Birmingham, Tuscaloosa
Stewart D. Waddell, MD, DLFAPA, Mind Matters, PC, Mountain Brook
Nawal Weaver, MD, Atrium Health, Charlotte, NC
Amanda Williams, MD, Gardenia Cove Mental Health, PC, Montgomery
Anupama Yedla, MD, UAB-Huntsville
| |
|
Learning Objectives
- Name three different theories of obesity, explain the role of hypothalamic dysfunction in obesity, and name two new treatments.
- Recall two historic examples of physician-assisted suicide approaches, two different legal principles, two ethical principles that apply, and two ways to respond to patients requesting assisted death.
- Explain legal use and proper handling of PDMP information, describe existing legal restraints (related to HIPAA and state law), and name three case scenarios where they will use PDMP.
- Define three potential causes of increased hospitalizations, and three interventions shown to reduce re-hospitalization rates of mentally ill patients.
- Describe evolutionary aspects of at least three different metal illnesses, explain the FSD model, and apply the new diagnostic framework to their clinical practice.
- Name criteria differentiating childhood bipolar disorder from DMDD, Fragile X syndrome, and anger overload, as well as name at least four DSM-5 differential diagnoses for children with severe outbursts, with the related specific and general treatments.
- List at least two preventative strategies, two drug combination treatments, two clinical tests, and two administrative interventions in the approach and treatment of dementia.
- Name at least 5 different evidence-based supplemental treatments and identify their psychiatric benefits, SEs and risks.
| |
The Alabama Psychiatric Physicians Association 2020 Fall Conference offers participants 6 hours of instruction.
| |
|
|
|
|
|
|
|
|
|
